The drugs belong to a class known as selective progesterone receptor modulators (SPRMs), which could potentially offer a welcome option in the future for women struggling with the condition. “Given the limited options for treatment as of now, any additional option that may be effective and that doesn’t present excess risks would be promising,” says Carly Snyder, MD, a reproductive psychiatrist in private practice in New York City, who treats many women with the condition.
At this time, SPRMs are used as an emergency contraceptive and for the treatment of uterine fibroids.
RELATED:
Premenstrual Dysphoric Disorder (PMDD) Can Be Debilitating